Biocon arm receives EMA approval to manufacture biosimilar Bevacizumab at Bengaluru facility Ruchika Sharma24 Jun 2024 12:15 PM ISTBengaluru: Biocon Biologics Ltd, a global, fully integrated biosimilars company and a subsidiary of Biocon Ltd, has received approval from the...
Biocon Biologics forays into US Ophthalmology market with USFDA nod for Yesafili Ruchika Sharma21 May 2024 11:30 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd, today announced that the U.S....
Eris Lifesciences acquires Biocon Biologics India branded formulation business for Rs 1242 crore Susmita Roy15 March 2024 1:51 PM ISTMumbai: Eris Lifesciences Ltd., a branded formulations company, has announced the acquisition of Biocon Biologics' India branded formulation...
Biocon Biologics secures US market entry date for Bmab 1200, a Proposed Biosimilar to Stelara Ruchika Sharma1 March 2024 3:30 PM ISTStelara (Ustekinumab) is a monoclonal antibody medication that prevents abnormal regulation of interleukin IL-12/23 associated immune diseases and has...
Biocon Biologics Biocon Campus (Site 1) facility gets 4 USFDA observations Ruchika Sharma1 March 2024 12:01 PM ISTBangalore: Biocon has recently announced that the U.S. Food and Drug Administration (USFDA) has issued Form 483s with 4 observations at...
Biocon Biologics, Sandoz Australia ink pact for biosimilars Trastuzumab, Bevacizumab Ruchika Sharma9 Feb 2024 12:30 PM ISTTrastuzumab is a biosimilar of Herceptin and Bevacizumab is a biosimilar of Avastin - both biosimilars are available on the PBS and utilised for the...
Biocon Biologics, Sandoz ink pact for distribution of immune disorder injection Adalimumab in Japan Ruchika Sharma23 Dec 2023 12:30 PM ISTAdalimumab BS for subcutaneous injection [FKB] is a biosimilar of Humira (generic name: adalimumab (genetical recombination)) and is indicated for...
Biocon arm completes integration of Viatris biosimilars business in 120 countries Ruchika Sharma19 Dec 2023 11:43 AM ISTBengaluru: Biocon Biologics Ltd (BBL), a subsidiary of Biocon Ltd, has announced the successful completion of the transition of the acquired...
Biocon arm concludes integration of Viatris biosimilar business in 31 European countries Ruchika Sharma30 Nov 2023 5:33 PM ISTBengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the integration of the Viatris' biosimilars business in 31...
Biocon arm gets UK MHRA marketing authorisation for ophthalmic drug Yesafili Ruchika Sharma14 Nov 2023 11:29 AM ISTIt is highly similar to the reference product Eylea (aflibercept).
Biocon Biologics to divest dermatology, nephrology branded formulations business units in India to Eris Lifesciences for Rs 366 crore Ruchika Sharma9 Nov 2023 11:45 AM ISTThe divestiture is expected to close by the end of Nov 2023, subject to customary closing conditions.
Ex Cipla Global CFO Kedar Upadhye appointed as new CFO of Biocon Biologics Ruchika Sharma20 Oct 2023 2:30 PM ISTBengaluru: Biocon Biologics Ltd, a subsidiary of Biocon Ltd has announced that the Board of Directors of Biocon Biologics have appointed Kedar Upadhye...
